By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


The Wistar Institute 

3601 Spruce Street

Philadelphia  Pennsylvania  19104-4268  U.S.A.
Phone: 215-898-3700 Fax:


Company News
The Wistar Institute And BioTime (BTX) Subsidiary OncoCyte Corporation Expand Agreement To Develop Molecular Diagnostic Test For The Detection Of Lung Cancer 8/18/2015 11:17:30 AM
BioTime (BTX) Release: OncoCyte Corporation’s Collaborators At The Wistar Institute Present Positive Clinical Interim Results Of Blood-Based Diagnostic Test For Non-Invasive Detection Of Lung Cancer 5/19/2015 1:15:03 PM
Kerafast And The Wistar Institute Announce Collaboration Through The Kerafast Fellows Program 3/16/2015 10:51:54 AM
BioTime (BTX)’s Subsidiary OncoCyte Corporation Announces Completion Of Multi-Site Clinical Study Of Lung Cancer Diagnostic By Collaborators At The Wistar Institute 10/3/2014 7:30:26 AM
"Rewired" Mice Show Signs Of Longer Lives With Fewer Illnesses, The Wistar Institute Study 8/1/2014 6:59:02 AM
BioTime (BTX)’s Subsidiary OncoCyte Corporation and The Wistar Institute to Collaboratively Develop Cancer Diagnostics 10/15/2013 9:53:58 AM
ReCyte Therapeutics and OncoCyte Corporation Release: BioTime (BTX) Licenses Technology for Key Regulatory Gene Underlying Cancer and Stem Cell Reprogramming from The Wistar Institute 1/24/2012 6:55:12 AM
Melanoma Patients Offered New Hope with Drug Combos, The Wistar Institute Study 12/17/2010 7:25:18 AM
One Company, The Wistar Institute, Aims to Re-purpose a Smallpox Vaccine to Battle HIV 8/24/2010 6:55:20 AM
"New" Human Adenovirus May Not Make for Good Vaccines, After All AdHu26 Demonstrates Same Fault as Previously Studied Vaccine Vectors, The Wistar Institute Study 8/12/2010 6:41:33 AM